Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flu-TBI vs Flu-Bu-ATG Conditioning in Allogenic Transplantation
NCT00894049Phase 2Completed
- Sponsor
- Institut Paoli-Calmettes
- Start
- Nov 2002
- Primary completion
- Feb 2013
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin rabbit, busulfan, fludarabine in hematologic malignancy, solid tumor, sponsored by Institut Paoli-Calmettes. Started Nov 2002; status: completed.
02
Drugs
antithymocyte globulin rabbitbusulfanfludarabine
03
Conditions
hematologic malignancysolid tumor
Beyond the preview
Go deeper on NCT00894049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00894049.